GGrantIndex
Sort

64,565 grants matching drug discovery

Neuropharmacology of Tramadol: Clinical Efficacy and Abuse Potential

$581,516
William Walton Stoops · University Of Kentucky · R01 · FY2009 · DA

Brain Biomarkers of Alcoholism and Abstinence

$581,511
Howard B Gutstein · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · AA

Probing the biochemical mechanism of amyloid disease

$581,479
Jeffery W Kelly · Scripps Research Institute, The · R37 · FY2012 · DK

Probing the biochemical mechanism of amyloid disease

$581,476
Jeffery W Kelly · Scripps Research Institute, The · R37 · FY2014 · DK

Histone Methyltransferases as a Target for Lung Cancer Prevention

$581,472
Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2015 · CA

Mapping the Plasma Exposome and its Association with Human Cardiovascular Disease

$581,433
Mohit Jain · University Of California, San Diego · R01 · FY2021 · ES

DRUG DISCOVERY CORE FACILITY (DDCF)

$581,402
Kinfe Ken Redda · Florida Agricultural And Mechanical Univ · G12 · FY2010 · RR

Accelerated molecular probe pipeline

$581,394
Gerard A Cangelosi · University Of Washington · U01 · FY2012 · AI

Reading Frame Correction for the Treatment of Batten Disease

$581,344
Michelle L Hastings · Rosalind Franklin Univ Of Medicine & Sci · R01 · FY2023 · NS

Expanding Genetic Understanding of Depression, Anxiety, and their Treatments

$581,341
Joel Gelernter · Yale University · R01 · FY2025 · MH

Behavior-based discovery of small-molecule modulators of neurochemical signaling pathways that underlie addiction

$581,283
Niels Ringstad · New York University School Of Medicine · R01 · FY2025 · DA

Reproducible, Unbiased Ligand Identification Assisted by Artificial Intelligence and Development of Ligand Reference Libraries

$581,271
Wladek Minor · University Of Virginia · R01 · FY2019 · GM

Multi-tissue High-throughput Proteomic and Genomic Study in Parkinson's Disease

$581,271
Bruno A. Benitez · Beth Israel Deaconess Medical Center · R01 · FY2025 · NS

Probing the biochemical mechanism of amyloid disease

$581,267
Jeffery W Kelly · Scripps Research Institute, The · R37 · FY2015 · DK

Validation of Occupancy Images from PET Data. A Novel Endpoint for Drug Discovery

$581,207
Evan D Morris · Yale University · R01 · FY2025 · EB

Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)

$581,173
Stephen W Byers · Georgetown University · R01 · FY2015 · CA

New Physical Methodologies for Genomic Analysis

$580,959
David C Schwartz · University Of Wisconsin-Madison · R01 · FY2010 · HG

Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma

$580,951
Yuan Chen · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA

Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma

$580,951
Yuan Chen · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA

Cell Systems to Pre-Clinical Models

$580,921
Yu Wang · University Of Michigan At Ann Arbor · U54 · FY2022 · NS

Rapid Response and Pilot Research Core

$580,872
Judith Wilde · George Mason University · U2C · FY2024 · DA

Development of an autologous humanized model of melanoma exploring human thymic education capacity

$580,793
Antonio Jimeno · University Of Colorado Denver · R01 · FY2018 · CA

Development of an autologous humanized model of melanoma exploring human thymic education capacity

$580,793
Antonio Jimeno · University Of Colorado Denver · R01 · FY2017 · CA

Development of an autologous humanized model of melanoma exploring human thymic education capacity

$580,793
Antonio Jimeno · University Of Colorado Denver · R01 · FY2019 · CA

Preclinical Time domain Fluorescence Tomography Platform

$580,767
Anand T.n. Kumar · Massachusetts General Hospital · R01 · FY2020 · CA